George T. Grossberg, Laurence J. Kinsella, editors.
Cham, Switzerland :
Springer,
[2018]
1 online resource
Intro; Foreword; Contents; Contributors; Chapter 1: Psychopharmacology for Neurologists; Clinical Vignette; Discussion; Scope of this Book; References; Chapter 2: General Principles of Psychopharmacology; Pharmacokinetics Vs. Pharmacodynamics; Pharmacokinetics; Pharmacodynamics; Drug Interactions; FDA Drug Approval; Off-Label Use; DEA Schedules of Drugs; Common Side Effects of Psychotropic Drugs and How to Manage Them; Neurotransmitter Systems; Specific Side Effects of Newer Psychotropic Drugs; Weight Gain; Sexual Dysfunction; Movement Disorders; Cardiovascular; Weight Loss; Hyponatremia.
Antidepressants for NeurologistsEvaluating and Adjusting Treatment; Case Vignette: Part 5; Evaluating Treatment Response; Continuing or Increasing the Antidepressant; Changing Antidepressants, if Not Effective; Goals and Duration of Treatment; Case Vignette: Part 6; Treat Residual Symptoms Fully; Duration of Treatment; Psychotherapy; Adverse Effects; Case Vignette: Part 7; Common Adverse Effects; Serious Adverse Effects; Other Adverse Effects; Discontinuation Syndrome; Neurological Illnesses; Epilepsy; Parkinson's Disease; Stroke; Multiple Sclerosis; Scales for Evaluating Treatment Response.
Case StudyEnsure Close Collaboration Among Various Prescribers; Start One Medication at a Time; Start Low and Go Slow, But Go; Hepatic and Renal Considerations; Knowledge of Available Formulations; Knowledge of Drug-Drug Interactions; Assess Role of Gender, Lifestyle, Racial/Ethnic Differences in Drug Metabolism and Tolerance; Monitoring for Drug Response, Toxicity, and Interactions; Avoid Introducing a Drug to Treat the Side Effects of Another Drug; Case Study; Reducing Medication Burden; Periodic Drug Tapering and Discontinuation if Symptoms Are Well-Controlled; Patient and Family Education.
Cognitive ImpairmentSerum Glucose Alterations; Gastrointestinal Issues; Rash; What Is a Black Box Warning and Which Psychotropes Have One?; Drug Withdrawal/Discontinuation; Pregnant and Nursing Women: Special Considerations; Hepatic/Renal Insufficiency: Impact on Dosing; Renal Insufficiency; Hepatic Insufficiency; Laboratory Monitoring; Lithium Serum Levels; WBC for Clozapine and Carbamazepine; TCAs for Depression; Antipsychotics; Conclusion; References; Chapter 3: Special Considerations for the Elderly; Basic Principles of Geriatric Psycho-pharmacotherapy; Document Target Symptoms.
Medication Cost/ReimbursementConclusion; References; Chapter 4: Antidepressants; Identifying Depression; Case Vignette: Part 1; Depression Screening; Subsyndromal Depression and Persistent Depressive Disorder; Case Vignette: Part 2; Subsyndromal Depression; Persistent Depressive Disorder (Dysthymia); Major Depressive Disorder; Case Vignette: Part 3; Diagnosing Major Depressive Disorder; Assessing Depression Severity; Completing the Assessment; Clinical Vignette: Part 3; Discussion; Prescribing an Antidepressant; Case Vignette: Part 4; Selecting an Antidepressant.
0
8
8
8
8
This book provides neurologists with a basic knowledge of psychiatric medications. It begins with general principles of psychopharmacology and the frequency of psychiatric illness in neurology patients. It goes on to cover psychoactive drugs in the elderly and treating behavioral symptoms of dementia. There is a special emphasis on drug-drug and drug-diet interactions that may be seen in clinical practice. Neurologists, residents, neuropsychiatrists, neuropsychologists and psychiatrists in training will find this practical guide invaluable in numerous clinical settings.